Sign in

CIK 0000926617

  • Non-accelerated filer
  • Smaller reporting company

Aspira Women's Health Inc.

Sign in to watch
Ticker
AWHL
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330595156
Phone
+1 512-519-0400
Business address
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
Former names
VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Gift SVP, Chief Science Officer gave 11,765 shares (gift)
  4. 4 Grant or award SVP, Chief Science Officer acquired 20,169 shares (grant or award)
  5. 4 Grant or award Director acquired 60,508 shares (grant or award)
  6. 4 Grant or award Director acquired 60,508 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market sale 10% owner sold 180,476 shares at an average $3.52 ($635,791)
  17. 4 Open-market buy VP-Chief Science Officer bought 250 shares at $0.43 ($106)
  18. 4 Open-market buy President and CEO bought 250 shares at $0.43 ($106)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 22 of 28 · 551 filings